The nuclear pore complex (NPC) controls the passage of macromolecules between the nucleus and cytoplasm, but how the NPC directly participates in macromolecular transport remains poorly understood. In the final step of mRNA export, the DEAD-box helicase DDX19 is activated by the nucleoporins Gle1, Nup214, and Nup42 to remove Nxf1•Nxt1 from mRNAs. Here, we report crystal structures of Gle1•Nup42 from three organisms that reveal an evolutionarily conserved binding mode. Biochemical reconstitution of the DDX19 ATPase cycle establishes that human DDX19 activation does not require IP 6 , unlike its fungal homologs, and that Gle1 stability affects DDX19 activation. Mutations linked to motor neuron diseases cause decreased Gle1 thermostability, implicating nucleoporin misfolding as a disease determinant. Crystal structures of human Gle1•Nup42•DDX19 reveal the structural rearrangements in DDX19 from an auto-inhibited to an RNA-binding competent state. Together, our results provide the foundation for further mechanistic analyses of mRNA export in humans.
T he flow of genetic information requires newly transcribed and processed mRNAs to be exported from the nucleus to the cytoplasm through nuclear pore complexes (NPCs). NPCs are massive macromolecular machines perforating the nuclear envelope, each composed of~1000 protein subunits (collectively termed nucleoporins) totaling to a molecular mass of 120 MDa in humans 1 . By fusing the inner and outer nuclear membranes, NPCs create pores through the nuclear envelope and simultaneously generate a passive diffusion barrier composed of disordered protein sequences enriched in phenylalanine-glycine (FG) repeats. Each NPC is composed of a~60 MDa symmetric core that is decorated by different proteins on its nuclear and cytoplasmic faces, which are referred to as the nuclear basket and cytoplasmic filament nucleoporins, respectively (Fig. 1a) .
The architecture of the symmetric core of the human NPC has recently been elucidated 2, 3 . In humans, the symmetric core is composed of an inner ring that resides in the plane of the membrane and two concentric outer rings that reside above the inner and outer nuclear membranes. The outer rings, which serve as the attachment sites for the nuclear basket and cytoplasmic 18 16 14 12 Volume (ml) Fig. 1 Gle1 is anchored to the nuclear pore complex through a competitive interaction with Nup98. a Cartoon schematic of the human nuclear pore complex (NPC). The circle highlights the region of the NPC to which the proteins used in this study localize. b Domain schematics for nucleoporins used in this study. Protein names and boundaries correspond to the human proteins. c Size exclusion chromatography (SEC) analysis of the interaction between Nup155 CTD , SUMO-Gle1 N , and Nup98 ΔFG . Purified Nup155 CTD •SUMO-Gle1 N complex was mixed with the indicated amounts of Nup98 ΔFG and loaded onto a Superdex 200 10/300 GL column. The gray bar indicates the fractions visualized with Coomassie-stained SDS-PAGE gels. d Left: table summarizing SEC analysis of Nup155 CTD variants for Nup98 ΔFG and SUMO-Gle1 N binding. See also Supplementary Fig. 2 . Right: the homologous positions were colored on the C. thermophilum Nup170•Nup145N structure (PDB ID 5HB0), indicating that the same binding surface is recognized by Nup98 ΔFG and SUMO-Gle1 N [2] . e Summary of the effect of Gle1 N alanine substitution variants on Nup155 CTD binding. Colored dots above the sequence of Gle1 N indicate the effect of the substitution, green for wild-type levels of complex formation, orange for reduced binding, or red for complete disruption. See also Supplementary Fig. 2 . f Identification of the Gle1 binding site suggests that the unassigned cytoplasmic density adjacent to bridging Nup155 molecules could contain Gle1 and its binding partners. Left: surface representation of the composite structure of the NPC 2 . Right: zoomed view of unassigned cytoplasmic density, with Nup155 shown in orange, Gle1 N binding site colored in green, and coat nucleoporin complexes shown in yellow filaments, are structurally connected to the inner ring via bridging Nup155 molecules. In addition to large interaction interfaces between scaffold proteins, the assembly of the symmetric core requires interactions mediated by flexible linker sequences residing in Nup98, Nup53, and Nup93 2, 4, 5 . In contrast, the molecular organization of the cytoplasmic filaments and nuclear basket remains poorly understood. Preparation of mRNAs for nuclear export is a highly coordinated process that begins co-transcriptionally and results in the addition and removal of mRNA-binding proteins during transcription and nuclear processing until an export-competent messenger ribonucleoprotein particle (mRNP) is formed 6 . Although some mRNAs may be exported through specialized pathways, the bulk of mRNA export is mediated by the evolutionarily conserved, heterodimeric transport factor complex Nxf1•Nxt1 7 . Nxf1•Nxt1 binds mRNAs without strong sequence preference and can shuttle mRNAs through the NPC diffusion barrier by binding to FG repeats. At the cytoplasmic face of the NPC, Nxf1•Nxt1-bound mRNPs encounter the cytoplasmic filament nucleoporins Gle1, Nup42, and Nup214, which specifically activate the DEAD-box helicase DDX19 to remove Nxf1•Nxt1 from the mRNP 8 . This spatial regulation of activity prevents reimport of mRNPs into the nucleus, and thus ensures the directionality of mRNA export.
DDX19 is a member of the DEAD-box helicase family, which are RNA-dependent ATPases composed of two RecA domains (referred to as DDX19 NTD and DDX19 CTD throughout the text) ( Fig. 1b) . Many insights into the regulation of DDX19 come from studies of the fungal homolog, Dbp5. Genetic, biochemical, and structural studies of the yeast proteins have revealed that the interaction between Gle1 and Dbp5 occurs via their C-terminal domains (CTDs) and is bridged by the small molecule inositol hexaphosphate (IP 6 ) 9-12 . In yeast, Gle1, IP 6 , and RNA cooperate to stimulate the ATPase activity of Dbp5, although the precise mechanism remains debated 10, 13 . The functional roles of Nup42 and Nup214 are also unclear. The interaction between Nup214 and DDX19 is required for steady-state localization of DDX19 to the NPC, but Nup214 binding also inhibits DDX19 activity [14] [15] [16] [17] . Nup42 binds to Gle1, but its contributions to DDX19 activity are unknown 18, 19 . DDX19 and Gle1 have been implicated in other cellular processes including transcription regulation, DNA damage response, translation initiation, and RNA processing [20] [21] [22] [23] [24] [25] . Impairment of nucleocytoplasmic transport through the NPC has been linked to both Huntington's disease and amyotrophic lateral sclerosis (ALS) [26] [27] [28] [29] [30] . Nucleocytoplasmic transport factors and nucleoporins, including Gle1, are genetic modifiers of disease in model systems and are mislocalized in both model organism and patient samples [26] [27] [28] [29] 31, 32 . Specific mutations of Gle1 are associated with lethal contracture congenital syndrome 1 (LCCS1), lethal arthrogryposis with anterior horn cell disease (LAAHD), and ALS 33, 34 . However, deciphering how defects in nucleocytoplasmic transport can lead to disease will require an improved understanding of the regulation of transport through the NPC.
To gain further mechanistic insight into the role of nucleoporins in mRNA export, we characterized the molecular architecture of the cytoplasmic filament nucleoporins involved in regulating DDX19 activity. We mapped the Gle1-binding site on Nup155 and found that it overlaps with the Nup98 binding site, thereby acquiring a spatial restraint for Gle1 localization in the NPC. Crystal structures of the Gle1•Nup42 complex from Saccharomyces cerevisiae, Chaetomium thermophilum, and Homo sapiens revealed the evolutionarily conserved structural basis of their interaction. Nup42 is critical for the thermostability of human Gle1, enabling Gle1 purification from a recombinant source and characterization of its role in human DDX19 activation, which unlike the yeast system does not require IP 6 binding. Crystal structures of the human Gle1•Nup42•DDX19 complex bound to ADP and AMP-PNP•Mg 2+ uncovered the adaptations that facilitate IP 6 -independent activation in humans and the specific Gle1-induced conformational changes that release DDX19 from an auto-inhibited state. Lastly, Gle1 mutations that are associated with motor neuron diseases possess severe thermostability defects, suggesting that nucleoporin misfolding contributes to disease.
Results
Gle1 and Nup98 recognize overlapping surfaces on Nup155. To gain a better understanding of the molecular architecture of the nucleoporins that regulate mRNA export, we set out to reconstitute the interactions with purified, recombinant proteins. We use the names of the human proteins unless otherwise specified. In humans, there are two splice variants of the Gle1 transcript, Gle1A and Gle1B, which encode proteins that are primarily localized in the cytoplasm or at the cytoplasmic face of the NPC, respectively 35 . We focused on the NPC-localized Gle1B, referred to as Gle1 throughout the text. Human Gle1 can be divided into three structural domains: an unstructured N-terminal region (Gle1 N , residues 1−123), a coiled-coil region (Gle1 CC , residues 124-355), and a highly conserved CTD (Gle1 CTD , residues 382-698) ( Fig. 1b ). Gle1 CTD is the domain that binds and stimulates DDX19, but previous studies have identified features in all three regions that are important for NPC localization 19, 36, 37 .
We began our analysis by focusing on the interaction between Gle1 and the adaptor nucleoporin Nup155 (Nup170 in fungi). Although the first 28 residues of Gle1 were previously shown to be sufficient for an interaction, we used a SUMO-fusion construct that also included several charged residues at the C-terminus to enhance protein solubility (SUMO-Gle1 N , residues 2-33) 37 . The Nup155 CTD (Nup155 CTD , residues 870-1391) and SUMO-Gle1 N formed a stoichiometric complex in size exclusion chromatography (SEC) experiments ( Fig. 1c ; Supplementary  Fig. 1a ). Nup155 CTD also contains a binding site for Nup98, which is both a component of the symmetric core of the NPC and of the cytoplasmic filaments 2,4 . Stoichiometric complex formation also occurred between Nup155 CTD and a construct of Nup98 lacking the FG repeat region (Nup98 ΔFG , residues 498-880) ( Supplementary Fig. 1b ). However, when we attempted to reconstitute a heterotrimeric complex by adding Nup98 ΔFG to Nup155 CTD •SUMO-Gle1 N , complex formation between Nup155 CTD and Nup98 ΔFG coincided with displacement of SUMO-Gle1 N , suggesting that the interactions were mutually exclusive ( Fig. 1c ; Supplementary Fig. 1a) . Similarly, addition of SUMO-Gle1 N to Nup155 CTD •Nup98 ΔFG failed to yield a heterotrimeric complex ( Supplementary Fig. 1b ). This effect was specific to Nup98, as addition of the N-terminal domain of Nup214 (Nup214 NTD ) to Nup155 CTD •SUMO-Gle1 N did not displace SUMO-Gle1 N ( Supplementary Fig. 1c ). In GST-pulldown experiments, Gle1 N efficiently outcompeted Nup98 ΔFG for Nup155 CTD binding, whereas conversely, Nup98 ΔFG could not outcompete Gle1 N , suggesting that Gle1 N binds with greater affinity to Nup155 CTD than Nup98 ΔFG ( Supplementary Fig. 1d ).
We next expanded upon previous mutational and structural analyses using the C. thermophilum proteins 2 . Amino acid substitutions at positions homologous to those that abolished binding for the C. thermophilum proteins also disrupted binding between human Nup155 CTD and Nup98 ΔFG , demonstrating that the mechanism of interaction between these two nucleoporins is evolutionarily conserved ( Fig. 1d ; Supplementary Fig. 2a ). Moreover, most residues that were critical for Nup98 ΔFG binding were also important for Gle1 N binding, except for two residues that each affected only one nucleoporin, indicating that Gle1 N and Nup98 ΔFG recognize overlapping surfaces on Nup155 CTD ( Fig. 1d ; Supplementary Fig. 2b ). Hydrophobic residues in Gle1 N were critical for Nup155 CTD binding, consistent with utilization of the same hydrophobic pockets as Nup98 ΔFG ( Fig. 1e ; Supplementary  Fig. 2c ).
In summary, we found that Gle1 N and Nup98 ΔFG recognize overlapping surfaces on Nup155 CTD . Nup155 molecules bridge the inner ring to the cytoplasmic and nuclear outer coat nucleoporin complex (CNC) double rings ( Fig. 1a) 2, 3 . Because Gle1 N efficiently outcompetes Nup98 ΔFG for binding, Gle1 would likely prevail for binding to Nup155 molecules exposed to the cytoplasmic face. Indeed, in the cytoplasmic outer ring, but not the nuclear outer ring, there is a volume of unaccounted density directly adjacent to the Nup155 CTD surface that binds Gle1 N (Fig. 1f ). Our analysis suggests this density contains the remainder of the Gle1 molecule and its binding partners.
Identification of a minimal Nup42 Gle1-binding fragment. We next focused on the interaction between Gle1 CTD and Nup42. Previous studies have shown that the C-terminal, non-FG repeat region of Nup42 binds Gle1 CTD19,38 . To identify the minimally sufficient fragment of Nup42 that recognizes Gle1, we monitored the localization of Gle1-GFP and mCherry-HA-tagged Nup42 variants in S. cerevisiae 39 . Nup42 truncations that contained residues 397-430 displayed nuclear rim staining consistent with localization to the NPC, whereas an Nup42 variant containing only residues 410-430 did not ( Fig. 2a ). From these results, we concluded that the Nup42 Gle1-binding motif (Nup42 GBM ) is located within residues 397-430 (See Supplementary Note 1).
When we recombinantly purified the minimal S. cerevisiae Gle1 CTD •Nup42 GBM complex, we noticed that the purified complex was more stable than apo Gle1 CTD , which typically requires the addition of IP 6 in purification buffers for stability 10 . This observation led us to test the effect of IP 6 and Nup42 GBM on the stability of Gle1 CTD using two different assays: differential scanning fluorimetry and a protein solubility assay. In both experiments, IP 6 potently improved Gle1 CTD stability, with saturating amounts of IP 6 shifting the melting temperature (T m ) from 22 to 37°C ( Fig. 2b; Supplementary Fig. 4a ). Nup42 GBM had an even more dramatic effect, increasing the T m from 22 to 46°C, and the presence of both IP 6 and Nup42 GBM shifted the T m of Gle1 CTD to 53°C ( Fig. 2b ; Supplementary  Fig. 4a ).
The difficulty of purifying human Gle1 CTD has previously prevented a detailed biochemical analysis of the human proteins, but the dramatic effect of yeast Nup42 GBM on Gle1 CTD stability led us to test whether human Nup42 GBM has the same effect on human Gle1 CTD . Co-purification of a homologous human Gle1 CTD •Nup42 GBM complex (containing Gle1 residues 382 −698 and Nup42 residues 379−423) resulted in dramatic improvements in the stability of Gle1 CTD and the yields increased from~0.5 to~50 mg/100 l of bacterial culture. In thermostability experiments, the T m of human Gle1 CTD increased from 37 to 50°C in the presence of Nup42 GBM ( Fig. 2c ; Supplementary Fig. 4b ). However, in contrast to the yeast proteins, IP 6 had almost no effect on thermostability for human Gle1 CTD ( Fig. 2c ; Supplementary Fig. 4b ). In summary, we identified an evolutionarily conserved C-terminal fragment of Nup42 that binds Gle1 and has a profound effect on Gle1 stability in both yeast and humans.
Evolutionary conservation of the Gle1−Nup42 interaction. To understand the molecular basis for the interaction between Gle1 CTD and Nup42 GBM and the resulting stabilization of Gle1 CTD , we determined the crystal structure of S. cerevisiae Gle1 CTD •Nup42 GBM at 1.75 Å resolution ( Fig. 2d ; Supplementary  Table 1 ). Nup42 GBM folds into a compact domain with a hydrophobic core that buries a solvent-exposed hydrophobic surface on Gle1 CTD , yielding an interaction interface area of 835 Å 2 ( Fig. 2d ; Supplementary Fig. 5a ; See Supplementary Note 2 for details). Consistent with the extensive interaction surface, the interaction between Gle1 CTD and Nup42 GBM was robust against several individual alanine substitutions in SEC experiments ( Supplementary Fig. 6a ). Instead, highly disruptive substitutions that introduced negative charge into the hydrophobic core (F414D or F409D/F414D) were required to completely disrupt the interaction between Gle1 CTD and Nup42 GBM ( Supplementary Fig. 6b ). In agreement with these results, Nup42 variants containing the F414D or F409D/F414D substitutions were unable to rescue Nup42 deletion in S. cerevisiae (Supplementary Fig. 3 ). In contrast, the F409D substitution in the Nup42 hydrophobic core did not ablate binding, but did alter the elution profile, suggesting a conformational difference in the complex ( Supplementary Fig. 6b ). Accordingly, an Nup42 variant harboring the F409D substitution only had a mild effect on growth at 37°C ( Supplementary Fig. 3a ).
To evaluate whether the mode of interaction observed for S. cerevisiae Gle1 CTD •Nup42 GBM was conserved in other eukaryotes, we determined the crystal structures of human Gle1 CTD •Nup42 GBM at 2.8 Å resolution and of C. thermophilum Gle1 CTD •Nup42 GBM in the presence and absence of IP 6 at 2.17 and 2.65 Å resolution, respectively ( Fig. 2e , f; Supplementary  Fig. 7a ; Supplementary Tables 1 and 2 ). The overall structure of Gle1 CTD is conserved between fungi and humans, with minor differences resulting from small insertions or different loop sizes ( Fig. 2g ; Supplementary Fig. 8 and Supplementary Movie 1). Both human and C. thermophilum Nup42 GBM adopt the same fold as S. cerevisiae Nup42 GBM and recognize the same surface on Gle1 CTD , with the critical hydrophobic residues nearly universally conserved ( Fig. 2i , j; Supplementary Figs. 8-11; See Supplementary Note 2 for details). Many of the critical interaction interfaces in the NPC likely possess a similar degree of structural conservation. Burial of the exposed hydrophobic residues and the thermodynamic favorability of Nup42 GBM binding and folding explain the large effect Nup42 GBM has on Gle1 CTD stability. Nup42 GBM binding may also help prevent Gle1 CTD from sampling partially unfolded states that could lead to aggregation. The remainder of Nup42 is comprised primarily of FG repeats. In yeast, deletion of these FG repeats was detrimental when combined with the deletion of other FG repeats in the cytoplasmic filaments 40 . Thus, in addition to ensuring the stability of Gle1 CTD , Nup42 GBM also has a role in anchoring FG repeats proximal to Gle1 in the NPC.
The IP 6 binding pocket is not conserved in metazoan Gle1. In yeast, activation of Dbp5, the fungal homolog of DDX19, requires the small molecule IP 6 , which binds to a highly positively charged pocket in Gle1 CTD adjacent to the Dbp5 binding surface and bridges the two proteins [9] [10] [11] . Our Gle1 CTD •Nup42 GBM structure reveals that Nup42 GBM interacts with Gle1 CTD at a surface that is distinct and well separated from the IP 6 binding pocket and the Dbp5 interface ( Supplementary Fig. 5a ) 10 . Thus, in order for Nup42 GBM binding to affect Dbp5 activation, it would have to do so through an allosteric mechanism. However, there were minimal conformational differences in Gle1 CTD between our Gle1 CTD •Nup42 GBM structure and the previously reported structure of Gle1 CTD •IP 6 •Dbp5 ( Supplementary Fig. 7b ) 10 . Similarly, C. thermophilum Gle1 CTD •Nup42 GBM undergoes minimal conformational changes upon IP 6 binding, which are mostly limited to a loop directly adjacent to the IP 6 pocket. IP 6 binds to C. thermophilum Gle1 CTD and to S. cerevisiae Gle1 CTD in a similar orientation, suggesting that IP 6 could function similarly in C. thermophilum as in S. cerevisiae ( Fig. 3a , b, d, e; Supplementary Fig. 7d ; See Supplementary Note 3). However, because there are no apo Gle1 CTD structures available, we could not exclude the possibility that Nup42 GBM binding caused Gle1 CTD to adopt the same conformation as the one observed upon IP 6 and Dbp5 binding. 
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In contrast to the IP 6 binding pockets of S. cerevisiae and C. thermophilum Gle1 CTD , the same location on the surface of the H. sapiens molecule was significantly altered, resulting in a substantial reduction in positive electrostatic potential ( Fig. 3a −f). This was the consequence of several positively charged residues that are essentially invariant in fungi (S. cerevisiae residues K264, K286, K333, and R374; C. thermophilum residues K225, R249, K327, and K374), but are not conserved in humans (V401, Q423, E482, and H523) ( electrostatic potential in this pocket may be a general feature of metazoan Gle1 ( Supplementary Fig. 12a ). Although there are two positions in human Gle1 that contained lysine residues not present in the fungal proteins, sequence conservation analysis also indicated that the positively charged residues in Dbp5 that bind IP 6 were not conserved in metazoans ( Supplementary Fig. 12b ). Combined, these structural observations raised the question of what roles Nup42 and IP 6 had on the activation of human DDX19.
The roles of IP 6 and Nup42 in DDX19/Dbp5 stimulation. To assess the role of IP 6 in DDX19 activation, we first tested whether complex formation between human DDX19 and Gle1 was dependent on IP 6 in SEC experiments. Consistent with previous reports, S. cerevisiae Dbp5 and Gle1 CTD •Nup42 GBM only formed a complex in the presence of IP 6 (Fig. 3g ) 10 . The interaction between C. thermophilum Gle1 CTD •Nup42 GBM and Dbp5 also required IP 6 , consistent with the evolutionary conservation of the IP 6 binding residues among fungi ( Fig. 3h ,; Supplementary  Fig. 12a ). In contrast, complex formation of the human proteins did not require IP 6 , and the presence of IP 6 instead partially reduced complex formation ( Fig. 3i ).
To directly test the effect of IP 6 and Nup42 on Dbp5 and DDX19 activity, we measured steady-state ATP hydrolysis rates with an NADH-coupled reaction using conditions identical to those previously reported 41 . Due to concerns that observed differences in activity were due to the stabilizing effects of IP 6 and Nup42 on Gle1 rather than direct roles in Dbp5/DDX19 activation, we measured ATP hydrolysis rates at multiple temperatures to decouple the effects due to stabilization from bona fide stimulatory roles. Because human DDX19 was intrinsically less active than S. cerevisiae Dbp5, we used fivefold higher concentrations of human DDX19, Gle1 CTD , Nup42 GBM , and IP 6 to ensure accurate measurements of ATPase activity. Furthermore, because Dbp5 and DDX19 are slow ATPases, we developed extensive protein purification protocols to ensure all of the measured activity was directly attributable to Dbp5 or DDX19 ( Supplementary Fig. 13a, b ).
In the yeast system, and across a range of RNA concentrations, the addition of Nup42 GBM to Gle1 CTD increased Dbp5 activity at 37°C, but this stimulatory effect was greatly diminished at 30°C, a temperature below the T m of Gle1 CTD •IP 6 , which is consistent with thermostability having a detectable effect in our assays ( Fig. 4a , c; Supplementary Fig. 13c ). Altogether, these data indicate that Nup42 GBM does not have a direct role in Dbp5 stimulation in the yeast system, but rather functions primarily to ensure Gle1 stability. In the yeast system, IP 6 was required for full stimulation of Dbp5 at all temperatures tested, indicating that in addition to its ability to stabilize yeast Gle1 CTD , IP 6 also has a direct role in Dbp5 stimulation ( Fig. 4a ; Supplementary Fig. 13c, d ). These results are in agreement with the observation that stable association of Gle1 CTD and Dbp5 requires IP 6 binding. In contrast, neither Nup42 GBM nor IP 6 were stimulatory in the human system at either temperature we tested ( Fig. 4b, d ; Supplementary Fig. 13e ).
Because differences in the IP 6 binding pocket in human Gle1 and DDX19 could have weakened the affinity for IP 6 rather than completely abolishing binding, we tested whether higher concentrations of IP 6 would stimulate DDX19. IP 6 stimulated Dbp5 activity in a dose-dependent manner that saturated at 1 μM (twice the Dbp5 concentration), but had no effect on human DDX19 activity up to concentrations of 100 μM, which is an upper estimate for the total (bound and free) IP 6 concentration in human cells (Fig. 4e) 42 . Additionally, IP 6 bound tightly to S. cerevisiae Gle1 CTD •Nup42 GBM in isothermal titration calorimetry experiments (ITC) with a dissociation constant (K d ) of~3 nM. However, no binding of IP 6 to human Gle1 CTD •Nup42 GBM was detected up to concentrations of 200 μM ( Supplementary Fig. 14) . Taken together, our results indicate that IP 6 binding is conserved in fungi but not in humans. Moreover, sequence analysis of other metazoan Gle1 and DDX19 sequences suggests that IP 6 binding may not be a feature of metazoan DDX19 activation in general, as IP 6 -binding residues are not present in a diverse array of metazoan sequences ( Supplementary Fig. 12a ). These results do not exclude the possibility that another small molecule may serve a similar function in humans as IP 6 does in fungi. However, unlike their fungal homologs, the human proteins alone are sufficient for complex formation.
Structural basis for IP 6 -independent human DDX19 activation. To understand the structural basis for IP 6 -independent DDX19 activation, we determined crystal structures of human Gle1 CTD •Nup42 GBM in complex with DDX19 in the presence of ADP or AMP-PNP•Mg 2+ at 3.6 and 3.4 Å resolution, respectively ( Fig. 5a, d ; Supplementary Table 3 ). Previous structural studies have revealed that DDX19 possesses an auto-inhibitory helix Nterminal to DDX19 NTD (residues 54-67) that can bind between DDX19 NTD and DDX19 CTD , preventing RNA binding or formation of a catalytically competent active site 43 . This helix appears to be conserved among metazoan DDX19 sequences, but is absent in their fungal Dbp5 homologs ( Supplementary Fig. 15 ). Therefore, we used a construct of DDX19 that contained the Nterminal auto-inhibitory helix but did not contain the flexible Nterminal extension (DDX19 ΔN53 , residues 54-479). In addition, we determined the crystal structure of apo DDX19 ΔN53 (AMP-PNP•Mg 2+ ) at 2.2 Å resolution ( Supplementary Fig. 16a ; Supplementary Table 3 ).
The heterotrimeric Gle1 CTD •Nup42 GBM •DDX19 ΔN53 complex exhibited similar conformations in the presence of ADP or AMP-PNP•Mg 2+ , with the auto-inhibitory helix still bound between DDX19 NTD and DDX19 CTD (Fig. 5a, d) . The surprising observation that AMP-PNP-bound DDX19 could also adopt the auto-inhibited conformation was confirmed by the structure of apo DDX19 ΔN53 (AMP-PNP•Mg 2+ ), which adopted an identical conformation as apo DDX19 ΔN53 (ADP) ( Supplementary  Fig. 16a ) 43 . The inhibited state does not differ structurally in the presence of ADP or ATP, as the nucleotide-binding pocket readily accommodates the additional phosphate and Mg 2+ ion, with minor changes in the sidechain conformations of K64 from the auto-inhibitory helix and E243 in the nucleotide binding pocket ( Supplementary Fig. 16b ). The Gle1 CTD −DDX19 CTD interface involves 40 Gle1 and 35 DDX19 residues to generate an interaction interface area of almost 1300 Å 2 ( Supplementary Fig. 10 ). As in the yeast complex, the human Nup42 GBM and DDX19 binding sites are on opposite sides of the Gle1 CTD molecule (Fig. 5a ). Most of the solvent exposed residues in helices α2 and α4 from Gle1 CTD are buried by the interaction involving two major interaction interfaces (Fig. 5b , c). In the first interface (interface 1), Gle1 CTD residues of helix α4 (H495, E491, and Q487) form an extensive hydrogen bond network with each other and DDX19 CTD 
(residues 380-382), as well as a salt bridge between Gle1 CTD residue E491 and DDX19 CTD residue K385 (Fig. 5b ). In the second interface (interface 2), the acidic C-terminal helix of DDX19 CTD is recognized by lysines on the Gle1 CTD surface, with salt bridges forming between DDX19 CTD residues D470, D472, and E475 and Gle1 CTD residues K416, K419, and K479 ( Fig. 5c ).
In several instances, DDX19 CTD residues (G329, T332, A334, and L471) packed directly against Gle1 CTD helices, interdigitating between the sidechains to form hydrophobic interactions ( Fig. 6b ).
Single amino acid substitutions in Gle1 CTD at these interfaces were sufficient to disrupt Gle1 CTD -mediated stimulation of DDX19 ( Fig. 5e ). We next searched for the structural differences between the human and yeast complexes that allow the human complex to form in the absence of IP 6 (Fig. 5f ). In the structure of S. cerevisiae Gle1 CTD •IP 6 •Dbp5 ΔN90 (ADP), the interface between Gle1 CTD and Dbp5 CTD is only~700 Å 2 in surface area, compared to~1300 Å 2 for the human complex, a difference compensated for in yeast through extensive contacts made by both proteins with a bridging IP 6 molecule ( Supplementary Figs. 5a, 10a ). For a summary of differences, see Supplementary Note 4. These observed structural differences result in a dramatic reduction of the local electrostatic potential at the human Gle1 CTD −DDX19 CTD interface compared to the yeast Gle1 CTD −DDX19 CTD interface ( Supplementary Fig. 17a, b ). Thus, for S. cerevisiae Dbp5 activation, the extreme negative charge of the IP 6 molecule would be necessary to overcome the electrostatic repulsion generated in forming such a positively charged pocket, but for human DDX19 this requirement no longer exists. To test whether IP 6 was indeed unable to bind, we also determined crystal structures of the human Gle1 CTD •Nup42 GBM • DDX19 ΔN53 complex grown in the presence of IP 6 or soaked with IP 6 , but observed no electron density for IP 6 in these crystals ( Supplementary Fig. 17d , e; Supplementary Table 4 ).
To gain further insight into how Gle1 CTD •Nup42 GBM binding facilitates DDX19 activation, we compared the structures of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 to those of apo DDX19 ΔN53 . The most apparent difference was a rotation of both DDX19 NTD and the auto-inhibitory helix away from DDX19 CTD , despite the auto-inhibitory helix still being bound between the two domains ( Fig. 6a ). In the structure of S. cerevisiae Gle1 CTD •IP 6 •Dbp5 ΔN90 (ADP), Dbp5 NTD is rotated even further away from Dbp5 CTD leading Dbp5 NTD to also contact Gle1 CTD (Fig. 5f) 10 . In yeast, a Gle1 CTD triple amino acid substitution (V513D/A516D/I520D) at the Dbp5 NTD binding interface abolishes Gle1-mediated stimulation of Dbp5 10 . A homologous triple amino acid substitution in human Gle1 CTD (G666D/I669D/ Q673D, DDD mutant) similarly abolished Gle1 CTD -mediated stimulation of DDX19, suggesting that the human proteins can also form the fully rotated conformation observed for the S. cerevisiae complex ( Supplementary Fig. 13f ). Therefore, we considered our structure as an early intermediate state that forms immediately after Gle1 CTD binding to DDX19, but before release of the auto-inhibitory helix and separation of DDX19 NTD and DDX19 CTD .
We next searched for the conformational changes in DDX19 CTD that might explain how Gle1 CTD -binding would stimulate ATPase activity. Several differences could be attributed to Gle1 CTD binding, including contacts causing ordering of the Cterminal helix and rearrangement of the trigger loop (residues 328-335) (Fig. 6a, b ). Through direct interactions between neighboring residues and relief of steric constraints, these changes propagated to the adjacent anchor loop (residues 390-403) (Fig. 6a, b) . Remodeling of the anchor loop removes contacts between DDX19 CTD and the auto-inhibitory helix, resulting in partial separation of DDX19 NTD and DDX19 CTD (Fig. 6c ). Remodeling of the anchor loop also results in ordering of a loop containing ATP-binding residues in DEAD-box motif VI (Fig. 6d ). For details, see Supplementary Note 5. In summary, Gle1 CTD binding to DDX19 CTD causes a cascade of conformational changes that partially releases the auto-inhibitory helix and prepares the residues involved in nucleotide binding to form the closed, active conformation.
Human Gle1•Nup42 relieves auto-inhibition. Our structural data are consistent with a mechanism wherein relief from inhibition by the N-terminal auto-inhibitory helix is one of the primary mechanisms for Gle1 CTD stimulation of DDX19 activity. Removal of the N-terminal 90 residues of S. cerevisiae Dbp5 increases unstimulated Dbp5 activity, but does not increase Gle1stimulated activity 10 . Similarly, removal of the N-terminal 53 residues also increased DDX19 activity, but activity in the presence of Gle1 CTD could not be examined 43 . To obtain a better understanding of the role of various regulatory elements in the Nterminal region of human DDX19, we tested the activation of a series of truncation variants that included DDX19 ΔN53 , DDX19 ΔN67 , DDX19 ΔN91 , and a variant of full-length DDX19, DDX19 S60D/K64D , containing two aspartate substitutions in the auto-inhibitory helix that would disrupt the inhibited state ( Supplementary Fig. 18a ; See Supplementary Note 6 for a detailed description of variants).
All four variants had higher basal ATPase activity than wildtype DDX19, consistent with inhibitory roles for the disrupted sequences ( Fig. 7a ). Removal of the entire unstructured Nterminal extension, DDX19 ΔN53 , yielded~2.5-fold higher basal ATPase activity, which was similar to the reported~3-fold higher basal ATPase activity upon removal of the entire Dbp5 Nterminal extension (Fig. 7a) 10 . Further N-terminal truncations, DDX19 ΔN67 and DDX19 ΔN91 , as well as the DDX19 S60D/K64D double amino acid substitution, exhibited~7.5-fold higher basal activity (Fig. 7a ). Strikingly, in contrast to wild-type DDX19, the activity of all four DDX19 variants was not stimulated by Gle1 CTD •Nup42 GBM , but instead was inhibited to an activity level comparable to wild-type DDX19 (Fig. 7a ). Moreover, RNA stimulated DDX19 activity in the absence of Gle1 CTD •Nup42 GBM for the DDX19 variants, yielding rates between~2-fold to~10fold faster than wild-type DDX19 (Fig. 7a ). For wild-type DDX19, addition of both RNA and Gle1 CTD •Nup42 GBM resulted in greater stimulation than either alone. However, for the variants Supplementary Fig. 13 . c RNA dependence of S. cerevisiae Dbp5 activation using the same conditions as in a, but with the indicated amounts of RNA performed at 30 and 37°C. d RNA dependence of H. sapiens DDX19 activation using the same conditions as in b, but with the indicated amounts of RNA performed at 30 and 37°C. e IP 6 dependence of (left) S. cerevisiae Dbp5 or (right) H. sapiens DDX19 activation using the same conditions as in a or b, respectively, but with the indicated amounts of IP 6 NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04459-3 ARTICLE that perturbed the auto-inhibitory helix, addition of both RNA and Gle1 CTD •Nup42 GBM yielded only a barely detectable further stimulation over RNA-mediated levels, resulting in fully stimulated activities~2-to 3-fold faster than wild-type DDX19 (Fig. 7a) . In contrast, the truncation variant that still possessed an intact auto-inhibitory helix, DDX19 ΔN53 , exhibited a~2-fold slower fully stimulated activity than wild-type.
These data explain several features of DDX19 activation. First, although human DDX19 has~7.5-fold lower ATPase activity than Dbp5, a large part of this difference can be attributed to the auto-inhibitory helix present in human DDX19 but not yeast Dbp5, as disruption of this helix yields activities only~3-fold slower than fully stimulated Dbp5. Second, the N-terminal 53 residues of DDX19 that precede the auto-inhibitory helix have a subtle but distinct role, possibly similar to the role of the Nterminal residues in yeast Dbp5. Lastly, the weak Gle1-mediated stimulation of the hyperactive variants in the presence of RNA suggests that relief from auto-inhibition is indeed a major mechanism for Gle1-mediated stimulation.
Human Nup214 is stimulatory in the presence of Gle1. We next analyzed the effect of the nucleoporin and mRNA export factor Nup214 on DDX19 activation in the context of Gle1 CTD •Nup42 GBM stimulation. Nup214 NTD binds to DDX19 NTD via an interface that partially overlaps with the RNA binding interface, and consequently, binding of Nup214 NTD to DDX19 NTD impairs RNA binding and RNA-mediated stimulation of DDX19 ATPase activity 14, 15 . In yeast, Nup214 NTD enhances ADP release from Dbp5 but the consequence of this effect is unclear, as Gle1 CTD stimulates Dbp5 to the same activity levels in the presence and absence of Nup214 NTD10, 44 .
In the human system, addition of Nup214 NTD did not affect basal DDX19 ATPase activity or activity in the presence of Gle1 CTD •Nup42 GBM (Fig. 7b ). Consistent with previous reports, Nup214 NTD inhibited RNA-mediated stimulation (Fig. 7b) 14, 15 . However, when DDX19 was stimulated by both Gle1 CTD •Nup42 GBM and RNA, the addition of Nup214 NTD further increased ATPase activity (Fig. 7b ). This effect was concentration dependent and more pronounced when Gle1 CTD • -Nup42 GBM was present in substoichiometric amounts (Fig. 7c ).
Thus, unlike what was found for the yeast system, Nup214 NTD can have a stimulatory effect in the context of Gle1-mediated DDX19 stimulation 10 . We next utilized an electrophoretic mobility shift assay to probe the effects of Gle1 CTD •Nup42 GBM and Nup214 NTD on RNA binding by DDX19. Whereas Gle1 CTD •Nup42 GBM enhanced DDX19 binding to RNA, Nup214 NTD inhibited DDX19 binding to a 53-nucleotide single-stranded RNA (Fig. 7d ). However, Gle1 CTD •Nup42 GBM rescued RNA binding in the presence of Nup214 NTD , consistent with its ability to rescue DDX19 from Nup214 NTD inhibition (Fig. 7b, d) . Thus, Nup214 not only recruits DDX19 to the cytoplasmic face of the NPC, but can also play an active role in promoting DDX19 ATPase activity (See Supplementary Note 7) .
Human disease mutations in Gle1. Several human diseases have been linked to Gle1 dysfunction, including ALS, Huntington's disease, and the related disorders LCCS1 and LAAHD, which lead to spinal cord motor neuron atrophy and premature death, often prior to birth 30, 33, 34 . For ALS and LCCS1/LAAHD, specific mutations have been mapped to Gle1 CTD . In ALS, three mutations have been associated with Gle1: a nonsense mutation that results in a truncated protein after residue 70, a splice site mutation that replaces the C-terminal 44 residues of Gle1 CTD with a novel 88-residue sequence, and a missense mutation leading to the amino acid substitution R697C 34 . LCCS1 and LAAHD are related disorders, in which the more phenotypically severe LCCS1 patients are typically homozygous for a 3-residue insertion at position 144 in the coiled-coil region of Gle1 (Fin Major ) and the less phenotypically severe LAAHD patients are compound heterozygous for the Fin Major mutation and a mutation in Gle1 CTD (V617M and I684T) 33 . The R569H variant in Gle1 CTD was identified in a patient diagnosed with the more severe LCCS1, suggesting it has a more potent effect than the V617M and I684T variants.
When mapped onto the structure of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 , none of the four amino acid substitutions directly participated in binding to Nup42 or DDX19 ( Fig. 7e; Supplementary Fig. 19a−d) . We next evaluated the Gle1 CTD •Nup42 GBM variants for thermostability and ability to stimulate DDX19. All three LCCS1/LAAHD mutations possessed altered thermostability that correlated with their phenotypic disease manifestation, with the R569H variant exhibiting the largest difference in T m , from 50°C for wild-type protein to 40°C for the disease variant (Fig. 7f) . In contrast, there were no substantial defects in ATPase stimulation for any of the disease variants (Fig. 7g ). In our crystal structures, R569 is involved in an extensive network of intra-molecular interactions ( Supplementary  Fig. 19a ), whereas V617 and I684 are both buried in hydrophobic cores ( Supplementary Fig. 19b, c) , supporting the conclusion that these mutations reduce the stability of Gle1 rather than affecting their ability to stimulate the activity of DDX19. Future work will need to address whether Gle1 stability is also a contributing factor in human disease.
Discussion
Using an interdisciplinary approach, we have garnered insight into the mRNA export events that occur at the cytoplasmic face of the NPC. Gle1 CTD plays an important organizational role by providing spatially separated binding sites for Nup42 GBM and the DEAD-box helicase DDX19/scDbp5. Strikingly, the Gle1 CTD •Nup42 GBM interaction mechanism is virtually identical in species separated by more than a billion years of evolution. A comprehensive structure-function analysis of DDX19 indicates that binding of Gle1 CTD •Nup42 GBM induces a conformational change in DDX19, thereby stimulating its ATPase activity. Biochemical analyses of Gle1 variants associated with human disease suggest that nucleoporin stability is a contributing factor in motor neuron disease.
While this paper was in revision, another group reported that both Nup42 and IP 6 directly affect Gle1-mediated DDX19 stimulation 45 . Informed by our studies of Gle1 CTD thermostability, we attribute the observed stimulation by Nup42 GBM to its role in increasing Gle1 CTD stability, rather than a direct role in activation. In the yeast system, we also observed apparent stimulation by Nup42 GBM at 37°C, which is the temperature used in the other study 46 . However, our thermostability experiments indicate that at 37°C, Gle1 CTD solubility is compromised (Fig. 2b) . In contrast, stimulation by Nup42 GBM at 30°C was largely undetectable ( Supplementary Fig. 13c ). This conclusion is further supported by examination of the crystal Supplementary Fig. 17 NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04459-3 ARTICLE structures, which revealed that Nup42 GBM binds Gle1 CTD on the opposite face as the scDbp5/DDX19-binding interfaces. Furthermore, we did not detect any stimulatory effect of Nup42 GBM in the human system.
In addition, we found that unlike yeast Dbp5, human DDX19 activation by Gle1 CTD does not require IP 6 . This conclusion was supported by multiple lines of evidence: (1) robust and indistinguishable ATPase stimulation of human DDX19 by Gle1 CTD both in the presence and absence of IP 6 , (2) human Gle1 CTD and DDX19 formed a complex in SEC experiments in the absence of IP 6 , (3) no binding of IP 6 to human Gle1 CTD •Nup42 GBM was detected in ITC experiments, (4) crystal structures uncover that the human Gle1 pocket corresponding to the yeast Gle1 IP 6 binding pocket possesses a dramatically reduced positive electrostatic surface potential, (5) IP 6 coordinating residues in yeast Dbp5 were not conserved in human DDX19, and (6) no electron density for IP 6 soaked or co-crystallized with IP 6 . We note that our studies were all performed with extensively purified proteins recombinantly expressed in bacteria ( Supplementary Fig. 13a, b) whereas DDX19 was purified from an insect cell expression system in the other study 45 . Future work needs to assess whether other proteins, small molecules, or post-translational modifications play a role in regulating DDX19 activity.
Combining these results, we can propose a working model of the DDX19 catalytic cycle ( Fig. 8; Supplementary Movie 3) . DDX19 is predominantly trapped in the auto-inhibited state, which can form in the presence of either ATP or ADP, although the ATP-and ADP-bound states could exhibit different dynamics for release of the auto-inhibitory helix. Gle1 binding facilitates release from auto-inhibition by first inducing conformational rearrangements in DDX19 CTD that partially open DDX19 and generate a cleft between DDX19 NTD and DDX19 CTD (Fig. 8, step  1) . Nup214 NTD binding can accelerate the opening of the domains leading to complete separation of the DDX19 NTD and DDX19 CTD , forming the conformation observed in the structure of S. cerevisiae Gle1 CTD •IP 6 •Dbp5 ΔN90 (Fig. 8, step 2) . Separation of DDX19 NTD and DDX19 CTD opens the nucleotide-binding pocket and enables exchange of ADP for ATP ( Fig. 8, step 3) . The auto-inhibitory helix could rebind and DDX19 would cycle between open and closed conformations until it encounters RNA (Fig. 8, step 4) . RNA binding favors the formation of the closed, catalytically active state and based on crystallographic data, would also trigger release of Gle1 due to rearrangements in DDX19. Specifically, the auto-inhibitory helix displaces DDX19's Cterminal helix and the mobile loop connecting the autoinhibitory helix resulting in a conformation that is incompatible with Gle1 binding (Fig. 8, step 5 ). This process leads to displacement of Nxf1•Nxt1, although future studies are necessary to establish how DDX19 specifically removes Nxf1•Nxt1. After ATP hydrolysis and subsequent dissociation of P i and RNA, DDX19 would then recycle back to the inhibited state and another cycle of ATP hydrolysis could then occur ( Fig. 8, step 6 ).
There remains a substantial gap between rates of ATP hydrolysis measured in vitro (~1 ATP/second) and rates of mRNA export termination observed in vivo (<0.1 s per mRNA) 46, 47 . A portion of this gap could be explained by a specific spatial organization at the cytoplasmic face of the NPC that efficiently accelerates the DDX19 cycle. Mapping of the Gle1-binding site on Nup155 provides a critical spatial restraint for the location of Gle1 and the entire cytoplasmic filament subcomplex in the NPC. Attempts to dock the newly determined structures of the human Gle1 CTD •Nup42 GBM •DDX19 ΔN53 into the cryoelectron tomographic reconstruction of the intact human NPC did not identify any unambiguous placements, although the rapid binding kinetics of DDX19 at the NPC suggest that it may not be present in the reconstructions ( Supplementary Fig. 20) 48, 49 . Furthermore, all of the cytoplasmic filament proteins studied here contain additional domains that may play important roles in DDX19 activity regulation. However, a complete characterization of these effects is expected to require the reconstitution of a fully assembled cytoplasmic filament nucleoporin complex, including the remaining domains of Nup42, Nup214, Gle1, their FG repeats, and their binding partners. This complex will need to be assembled onto the human CNC rings that serve as a scaffold in the intact NPC and assayed with Nxf1•Nxt1-bound mRNAs. The results presented here provide a rich foundation for the design of these experiments.
Lastly, the effect of Nup42 on Gle1 stability highlights protein instability as a potent modifier of Gle1 function, as the Gle1 CTD fold is unstable at physiological temperatures in vitro in the absence of its cofactors. The effects of mutations associated with human disease in our thermostability experiments largely correlated with their phenotypic severity, suggesting that protein stability may be a contributing factor in these diseases. Interestingly, measurements of S. cerevisiae Gle1 CTD •IP 6 thermostability in the absence of Nup42 GBM in vitro matched the temperatures at which we observed mislocalization of Gle1 in yeast cells, presumably a result of misfolding and subsequent dissociation from the NPC (Fig. 2a) . A similar phenomenon occurs in human cells, as the mutations that destabilize human Gle1 CTD have previously been found to possess NPC localization defects 49 . Overall, our results reinforce the link between mislocalization or aggregation of proteins involved in RNA metabolism and nucleocytoplasmic transport with human disease. Future studies that build upon the results reported here to determine the contribution of protein destabilization in disease models should provide greater insight into the mechanisms underlying motor neuron disease.
Methods
Chemicals and reagents. Chemicals were purchased from Sigma at the highest purity available unless otherwise noted.
Construct generation. DNA fragments were amplified using the polymerase chain reaction. SUMO-tagged proteins were cloned into a modified pET28a vector 50 . GST-tagged proteins were cloned into a pGEX-6P-1 vector. His 6 -tagged proteins were cloned into a modified pET28a vector 51 . S. cerevisiae and H. sapiens Gle1 CTD •Nup42 GBM were cloned into a modified pETDuet-1 vector with Nup42 GBM in the first site and Gle1 CTD in the second site. Mutants were generated using the QuikChange mutagenesis protocol and confirmed by DNA sequencing. Supplementary Table 5 .
Details of bacterial expression constructs and expression conditions are shown in
Protein expression and purification. Proteins were expressed in E. coli BL21-CodonPlus(DE3)-RIL cells (Stratagene) in Luria-Bertani media and induced at an OD 600 of~0.6 with 0.5 mM IPTG (Gold Biotechnology). Unless indicated otherwise, cells were harvested by centrifugation and resuspended in a buffer containing 20 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM 2-mercaptoethanol (β-ME), and 15 mM imidazole, supplemented with complete EDTA-free protease inhibitor cocktail (Roche) and flash frozen in liquid nitrogen. Cells were supplemented with 1 mg deoxyribonuclease I (Roche), lysed with a cell disruptor (Avestin), and centrifuged at 4°C and 30,000 × g for 1 h. Supernatants were loaded onto an Ni-NTA affinity column (GE Healthcare) equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM β-ME, and 15 mM imidazole and eluted with a linear gradient of imidazole concentration to 500 mM. Eluted proteins were dialyzed overnight with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 4 mM β-ME, and 15 mM imidazole and subsequently purified through affinity, ion exchange, and SEC. hsGle1 CTD •His 6 -hsNup42 GBM variants, scGle1 CTD •His 6 -scNup42 GBM , and His 6 -scGle1 CTD were grown for 18 h at 18°C. His 6 -ctGle1 CTD was co-expressed with GST-ctNup42 GBM and grown for 3 h at 37°C. After elution from the Ni-NTA column, the His 6 tag and the GST tag were removed by cleavage with PreScission Supplementary Fig. 18a . b Analysis of the effect of Nup214 NTD on DDX19 stimulation. See also Supplementary Fig. 18 . c Analysis of concentration dependence of Nup214 NTD on DDX19 stimulation in the presence of RNA and Gle1 CTD •Nup42 GBM . d Electrophoretic mobility shift assay analysis of the effect of Gle1 CTD •Nup42 GBM (1 μM) and Nup214 NTD (2 μM) on DDX19 (1 μM) binding to a 53-nucleotide ssRNA. RNA was visualized by staining with SYBR gold. The proteins loaded in each lane were also visualized with a Coomassie-stained SDS-PAGE gel, shown below. e Mapping single amino acid substitutions associated with human diseases LCCS1/LAAHD and ALS onto the structure of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (ADP). Coloring is the same as in Fig. 5a . See also Supplementary Fig. 19 . His 6 -SUMO-hsGle1 CTD was grown for 18 h at 18°C and purified as hsGle1 CTD •His 6 -hsNup42 GBM , except the His 6 -SUMO tag was removed by Ulp1 cleavage.
His 6 -hsDDX19 variants, His 6 -scDbp5 and His 6 -SUMO-ctDbp5 were grown for 18 h at 18°C. Cells were harvested by centrifugation and resuspended in a buffer containing 20 mM TRIS (pH 8.0), 500 mM NaCl, 4 mM β-ME, 15 mM imidazole, and 5% (v/v) glycerol, supplemented with Complete EDTA-free protease inhibitor cocktail (Roche) and flash frozen in liquid nitrogen. After lysis and centrifugation, the supernatant was loaded onto an Ni-NTA column equilibrated in a buffer a (1) (2) Crystallization and structure determination. S. cerevisiae Gle1 CTD •Nup42 GBM was crystallized at 23°C with the hanging drop method using 1 μl of protein solution (22.5 mg/ml) and 1 μl of reservoir solution, containing 0.1 M HEPES (pH 8.2), 11% (w/v) PEG 3350, and 0.2 M L-Proline. Crystals were cryoprotected with a solution identical to the reservoir solution, but supplemented with 30% (v/v) ethylene glycol. X-ray diffraction data were collected at beamline 12-2 at the Stanford Synchotron Radiation Lightsource (SSRL) with a wavelength of 0.9795 Å and processed with the XDS package 52 . The structure was solved by molecular replacement with Phaser, using the structure of Gle1 CTD (PDB ID 3RRN) as a search model 10, 53 . The structure was refined using the PHENIX package with TLS refinement 54 . One of the Gle1 molecules in the asymmetric unit displays two distinct conformations for half the molecule and was modeled as two alternate conformations for the entire residue range. The final structure was refined to R work and R free values of 18.5 and 21.1%, respectively, with excellent geometry (98.3% of residues in favored region of the Ramachandran plot, 1.7% in the allowed region, and 0.0% outliers; MolProbity clashscore 1.92; MolProbity score 0.96) 55 .
H. sapiens Gle1 CTD •Nup42 GBM was crystallized at 23°C with the hanging drop method using 1 μl of protein solution (20 mg/ml) and 1 μl of reservoir solution, containing 0.2 M sodium potassium phosphate (pH 7.6) and 26% (w/v) PEG 3350. Crystals were cryoprotected by gradual supplementation of ethylene glycol in 5% steps to a final concentration of 30% (v/v). X-ray diffraction data were collected at beamline 23-ID-D at the Advanced Photon Source (APS) with a wavelength of 0.9794 Å and processed with the XDS package 52 . The diffraction data were anisotropic, with diffraction limits along the three principal components of 2.8, 3.1, and 3.1 Å. The structure was solved by molecular replacement with Phaser, using the structure of S. cerevisiae Gle1 CTD (PDB ID 3RRN) as a search model 10, 53 . Refinement was performed using torsion NCS restraints with the PHENIX package using anisotropically truncated and scaled data generated using the UCLA-DOE anisotropy server 54, 56 . The final structure was refined to R work and R free values of 24.5 and 27.4%, respectively, with excellent geometry (95.2% of residues in favored region of the Ramachandran plot, 4.8% in the allowed region, and 0.0% outliers; MolProbity clashscore 1.88; MolProbity score 1.31) 55 .
C. thermophilum Gle1 CTD •Nup42 GBM was crystallized at 23°C with the hanging drop method using 1 μl of protein solution (10 mg/ml) and 1 μl of reservoir solution, containing 0.1 M MES (pH 6.3) and 12% (w/v) PEG 20,000. Crystals were cryoprotected by gradual supplementation of ethylene glycol in 5% steps to a final concentration of 25% (v/v). X-ray diffraction data were collected at beamline 23-ID-D at APS with a wavelength of 1.0332 Å and processed with the XDS package 52 . The structure was solved by molecular replacement with Phaser, using the structure of H. sapiens Gle1 CTD as a search model 53 . The structure was refined with torsion NCS restraints using the PHENIX package 54 . The final structure was refined to R work and R free values of 24.0 and 27.7%, respectively, with excellent geometry (97.5% of residues in favored region of the Ramachandran plot, 2.5% in the allowed region, and 0.0% outliers; MolProbity clashscore 3.34; MolProbity score 1.22) 55 .
C. thermophilum Gle1 CTD •Nup42 GBM •IP 6 was crystallized at 23°C with the hanging drop method using 1 μl of protein solution (7.5 mg/ml) and 1 μl of reservoir solution, containing 10 mM zinc sulfate heptahydrate, 0.1 M MES (pH 6.3), and 18% (v/v) Polyethylene glycol monomethyl ether 550. Crystals were improved by microseeding. Crystals were cryoprotected by gradual supplementation of ethylene glycol in 5% steps to a final concentration of 25% (v/ v). SeMet-labeled crystals were grown using the same conditions. X-ray diffraction data were collected at beamline 12-2 at SSRL with a wavelength of 0.9792 Å for SeMet crystals and 1.0332 Å for native crystals, and processed with the XDS package 52 . The structure was solved using Crank2, using the structure of H. sapiens Gle1 CTD as an initial search model 57, 58 . The structure was refined using the PHENIX package 54 . The presence of Zn 2+ ions was confirmed using anomalous difference Fourier maps. The final structure was refined to R work and R free values of 19.3 and 23.0%, respectively, with excellent geometry (98.3% of residues in favored region of the Ramachandran plot, 1.7% in the allowed region, and 0.0% outliers; MolProbity clashscore 0.56; MolProbity score 0.69) 55 .
For crystallization of the H. sapiens Gle1 CTD •Nup42 GBM •DDX19 ΔN53 , the complex was reconstituted by mixing equimolar amounts of purified Gle1 CTD •Nup42 GBM and DDX19 ΔN53 to form a 400 μM stock solution. The stock solution was supplemented with 400 μM ADP or AMP-PNP and 400 μM MgCl 2 . Protein stock solutions were diluted with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 5 mM DTT, 1 mM MgCl 2 , and 1 mM ADP or AMP-PNP. Crystals of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (ADP) were grown at 4°C with the hanging drop method using 1 μl of protein solution (7.5 mg/ml) and 1 μl of reservoir solution, containing 13% (w/v) PEG 3350 and 0.2 M sodium potassium phosphate. Crystals of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) were grown at 4°C with the hanging drop method using 1 μl of protein solution (5 mg/ ml) and 1 μl of reservoir solution in 15% (w/v) PEG 3350 and 0.3 M sodium potassium phosphate (pH 6.6). Crystals were cryoprotected by gradual supplementation of ethylene glycol to a final concentration of 25% (v/v) in 5% (v/v) steps.
Diffraction data for Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (ADP) were collected at beamline 23-ID-D at APS with a wavelength of 1.0333 Å and processed with XDS 52 . The diffraction data were anisotropic, with diffraction limits along the three principal components of 3.6, 3.7, and 4.0 Å. The crystal structure was solved by molecular replacement with Phaser, using the structure of H. sapiens Gle1 CTD •Nup42 GBM and H. sapiens DDX19 (PDB ID 3EWS) as search models 43 . Refinement was performed using torsion NCS restraints with the PHENIX package using anisotropically truncated and scaled data generated using the UCLA-DOE anisotropy server 54, 56 . The final structure was refined to R work and R free values of 23.2 and 28.1%, respectively, with excellent geometry (95.9% of residues in favored region of the Ramachandran plot, 4.1% in the allowed region, and 0.0% outliers; MolProbity clashscore 3.86; MolProbity score 1.45) 55 .
Diffraction data for Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) were collected at the Frontier Microfocusing Macromolecular Crystallography beamline (FMX) at the National Synchotron Lightsource-II (NSLS-II) with a wavelength of 0.9793 Å. The crystals grew in space group P2 1 but were non-merohedrally twinned with the twin domains related by a 180°rotation along a. Diffraction data were integrated with DIALS and scaled with AIMLESS 59, 60 . The structure was solved by molecular replacement with Phaser, using the structures of H. sapiens Gle1 CTD •Nup42 GBM and H. sapiens DDX19 (PDB ID 3EWS) as search models 43, 53 . The diffraction data were anisotropic, with diffraction limits along the three principal components of 3.4, 3.7, and 4.2 Å. Refinement was performed with PHENIX using anisotropically truncated and scaled data generated with the UCLA-DOE anisotropy server 54, 56 . The final structure was refined to R work and R free values of 26.1 and 31.3%, respectively, with excellent geometry (95.0% of residues in favored region of the Ramachandran plot, 5.0% in the allowed region, and 0.0% outliers; MolProbity clashscore 2.72; MolProbity score 1.43) 55 .
For the structures of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) grown in the presence of or soaked with IP 6 , crystals of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) were grown in a drop additionally supplemented with 0.5 mM IP 6 or soaked for 4 days with 0.5 mM IP 6 , respectively. Crystals grown or soaked with IP 6 were cryoprotected with solutions supplemented with 0.5 mM IP 6 . Diffraction data were collected at beamline 23-ID-D at APS, integrated with DIALS and scaled with AIMLESS 59, 60 . The structures were solved by direct substitution of the coordinates of the structure of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) and refined with the PHENIX package 54 . The structure of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) soaked with IP 6 was refined to R work and R free values of 24.6 and 29.7%, respectively, with a MolProbity score of 1.38 55 . The structure of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) co-crystallized with IP 6 was refined to R work and R free values of 25.8 and 31.3%, respectively, with a MolProbity score of 1.41 55 . Simulated annealing omit maps were calculated using the PHENIX package by omitting all ligand molecules 54 .
Crystals of DDX19 ΔN53 (AMP-PNP•Mg 2+ ) grew during crystallization trials of Gle1 CTD •Nup42 GBM •DDX19 ΔN53 (AMP-PNP•Mg 2+ ) in heavy precipitate. The reservoir solution contained 0.1 M malonate, imidazole, borate (MIB) buffer (pH 5.0) and 13% (w/v) PEG 1500. Crystals were cryoprotected with the reservoir solution supplemented with 20% (v/v) ethylene glycol. X-ray diffraction data were collected at beamline 23-ID-D at APS with a wavelength of 1.0333 Å and the data were integrated with DIALS and scaled with AIMLESS 59, 60 . The crystal structure was solved by molecular replacement using the structure of DDX19 ΔN53 (ADP) (PDB ID 3EWS) 43 . The structure was refined with TLS groups using the PHENIX package 54 . The final structure was refined to R work and R free values of 20.7 and 24.8%, respectively, with excellent geometry (98.9% of residues in favored region of the Ramachandran plot, 1.1% in the allowed region, and 0.0% outliers; MolProbity clashscore 2.04; MolProbity score 0.97) 55 .
For details of the data collection and refinement statistics for all structures, see Supplementary Tables 1-4 . For representative views of electron density for all structures, see Supplementary Figure 21 .
Analytical size-exclusion chromatography. Protein−protein interaction experiments were carried out on a Superdex 200 10/300 GL or Superdex 75 10/300 GL gel filtration column equilibrated in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT (when present, 0.5 mM IP 6 was added to the buffer). The different combinations were mixed and incubated for 30 min on ice using a twofold molar excess of the smaller component. Complex formation was evaluated by comparing the mobility on the gel filtration column of pre-incubated proteins versus individual proteins. Complex formation was confirmed by SDS-PAGE of the protein-containing fractions, followed by Coomassie brilliant blue staining.
GST pull-down interaction analysis. Glutathione-S-transferase (GST) pull-down experiments were performed with purified GST-Nup155 CTD , Nup98 ΔFG , and SUMO-Gle1 N . 25 μl of Glutathione Sepharose 4 Fast Flow beads (GE Healthcare) were equilibrated with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl and 5 mM DTT. GST-Nup155 CTD (20 μM) was preincubated for 30 min with a twofold molar ratio of either Nup98 ΔFG or SUMO-Gle1 N on ice. Preincubated mixtures were subsequently incubated with 0, 0.5, 1, 1.5, 2, 4, or 8-fold molar ratios of the other protein for another 30 min on ice. Mixtures were then incubated with pre-equilibrated glutathione-coupled sepharose beads for 30 min and washed five times with a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl and 5 mM DTT and centrifuged at 500 × g at 4°C. Bound protein was eluted from the beads with 25 μl buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, 5 mM DTT, and 10 mM reduced glutathione.
Yeast strain generation. The nup42Δ/gle1-GFP strain was generated in a haploid BY4741 parental strain by first introducing the natNT2 cassette by homologous recombination into the nup42 gene, followed by three rounds of selection on yeast extract peptone dextrose (YPD) plates containing Nourseothricin (Gold Biotechnology) 61 . Subsequently, a GFP-kanMX cassette was inserted into the Cterminus of Gle1 followed by three rounds of selection on YPD plates containing G418 61 . Nup42-mCherry-3xHA variants were introduced using a modified pRS415 plasmid followed by two rounds of selection on plates containing leucine-depleted synthetic dextrose complete medium (SDC-LEU). For details of yeast strains and constructs, see Supplementary Table 6 .
Yeast live cell fluorescence. Cells were grown in SDC-LEU medium to mid-log phase at 30°C and shifted to 42°C for 3 h. For fluorescence imaging, cells were pelleted by centrifugation for 2 min at 650 × g, resuspended in water, and imaged using a Carl Zeiss Observer Z.1 equipped with a Hamamatsu camera C10600 Orca-R2.
Yeast growth assay. For growth analysis, cells were grown in SDC-LEU medium at 30°C to an OD 600 of 0.2. Fifteen microliters of a tenfold dilution series was spotted onto plates containing SDC-LEU medium, which were incubated at 30 and 37°C.
Western blot analysis. The expression levels of Nup42-mCherry-3xHA variants were assessed for the S. cerevisiae nup42Δ/gle1-GFP strain. Transformed cells were selected twice on SDC-LEU plates before analysis. Protein extraction from cells was performed via NaOH and SDS treatment, using a modified protocol 62 . Specifically, cells were grown at 30°C to an OD 600 of ∼1.0 before harvesting 10 ml of culture by centrifugation for 5 min at 3000 × g. Cell pellets were resuspended in 100 μl of 0.3 M NaOH and incubated for 5 min on ice, pelleted by centrifugation at 3000 × g, washed with water twice, and resuspended in a buffer containing 20 mM TRIS (pH 8.0), 250 mM NaCl and 2% (w/v) SDS, incubated at 80°C for 10 min followed by centrifugation at 30,000 × g for 4 min. The supernatant was collected, diluted with SDS loading dye, and boiled for 3 min prior to loading on a SDS-PAGE gel. Western blot analysis of Nup42-mCherry-3xHA variants was performed with a 1 h incubation at room temperature with mouse anti-HA antibody (Covance; MMS-101P; 1:5000 dilution) and a 1 h incubation at room temperature with an antimouse antibody coupled to alkaline phosphatase (Promega; S3721; 1:5000 dilution) visualized by color development using SIGMAFAST 5-bromo-4-chloro-3-indolyl phosphate (BCIP)/nitro blue tetrazolium (NBT) tablets (Sigma; B5655). Equal loading was established with an overnight incubation at 4°C with rabbit antihexokinase antibody (US Biological; H2035-02; 1:10,000 dilution) and 1 h incubation at room temperature with a goat anti-rabbit antibody fused to an IR800 fluorescent probe (Li-Cor, 926-32211; 1:10,000 dilution) imaged with an IR imager (Li-Cor Odyssey) using the 800 nm channels in a single scan at 169 μm resolution and a scan intensity of 5. Antibodies were diluted in TBS-T supplemented with 3% (w/v) milk powder and washes were carried out in TBS-T.
Differential scanning fluorimetry assay. Differential scanning fluorimetry was performed using a previously described protocol 63 . Using a real-time PCR instrument (Bio-Rad C1000 96-well Thermal Cycler), fluorescence of a 20 μl mixture of 5 μM purified protein and 5× SYPRO orange dye (Invitrogen) was measured once per minute while the temperature was increased 1°C/min from 4 to 95°C. Reactions were performed in 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. When present, IP 6 was supplemented to 25 μM for yeast proteins and 100 μM for human proteins. The reported T m values were determined by finding the temperature corresponding to the maximum of the first derivative of the thermal melting curve. Traces represent the average of three experiments.
Pelleting thermostability assay. Fifty-microliter samples of purified protein (10 μg each) were incubated for 30 min at indicated temperatures between 25 and 55°C
. Soluble and pellet fractions were isolated by centrifugation at 30,000 × g for 35 min at 4°C. Reactions were performed in a buffer containing 20 mM TRIS (pH 8.0), 100 mM NaCl, and 5 mM DTT. When present, IP 6 was added to a final concentration of 20 μM. Proteins were resolved by SDS-PAGE gel and visualized with Coomassie brilliant blue staining.
NADH-coupled ATPase assay. Steady-state ATPase activity rates were determined at 30 and 37°C for scDbp5 and hsDDX19 using previously established conditions 41 . The reaction mixture (80 μl) contained purified scDbp5 and hsDDX19 (WT and variants) at 0.5 and 2.5 μM, respectively. Unless otherwise noted, all other S. cerevisiae and H. sapiens proteins (Gle1 CTD , Gle1 CTD • -Nup42 GBM , or Nup214 NTD ) were present at concentrations of 1 and 5 μM, respectively. When present, polyA RNA with length ranging between 465 and 660 bases (GE Healthcare, 27411001) was added to a final concentration of 0.1 mg/ml. When present, IP 6 was supplemented to a final concentration of 2 and 10 μM for yeast and human, respectively, unless otherwise noted. The reaction mixture contained 30 mM HEPES (pH 7.5), 100 mM NaCl, 2 mM MgCl 2 , 1 mM DTT, 6 mM phosphoenolpyruvate (PEP, Alfa Aesar), 1.2 mM NADH, 1.6 μl pyruvate kinase (PK)/lactate dehydrogenase enzyme solution (LDH), and 2.5 mM ATP, unless otherwise noted.
For each reaction, two separate mixtures were prepared and kept separate until initiation of the reaction. The first mixture, containing the protein components, IP 6 , polyA RNA, and buffer (HEPES, NaCl, and MgCl 2 ), was prepared to a final volume of 20 μl and incubated on ice. The second mixture, containing buffer, DTT, PEP, NADH, ATP, and PK/LDH, was prepared to a final volume of 60 μl and dispensed into a 96-well plate. Reactions were initiated by addition of the protein mixture. Plates were centrifuged at 4000 × g for 2 min at 4°C prior to being loaded in the pre-warmed plate reader. A 340 was measured every 30 s for 30 min using a FlexStation 3 microplate reader (Molecular Devices). Rates were calculated by fitting the linear portion of the reaction. Reported rates were determined by dividing the rate of ATP consumption by the concentration of DDX19/Dbp5 in the reaction. All values reported are the average of three experiments.
Isothermal titration calorimetry experiments. ITC measurements were performed at 21°C using a MicroCal ITC200 Calorimeter (GE Healthcare/Malvern) in a buffer containing 100 mM HEPES (pH 7.4), 100 mM NaCl, 2 mM MgCl 2 , and 4 mM β-ME. Protein solutions were dialyzed overnight against ITC buffer and IP 6 was dissolved in the dialysate. All measurements were performed in triplicate. Because of the acidic nature of IP 6 , the heat generated from dilution was subtracted for baseline correction. Baseline corrected data were analyzed with Origin 7.0 software. For S. cerevisiae Gle1 CTD •Nup42 GBM , cell and syringe concentrations NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04459-3 ARTICLE
